https://www.selleckchem.com/products/gs-9973.html
A significant lower FMD (3.5 ± 1.7 vs 5.9 ± 1.5%, P less then 0.001) and slower oxygen resaturation rate (0.78 ± 0.4 vs 1.14 ± 0.4%·s-1, P = 0.02 in HIV as compared to N-HIV group were observed. In conclusion, our findings demonstrated that HIV-infected patients had reduced FMD and impaired muscle oxygenation during exercise recovery compared to non-HIV individuals. BACKGROUND In a randomized trial (CREATE-X), patients with residual disease after standard neoadjuvant chemotherapy had improved survival with the addition of adjuvant cap
Like
Comment
Share
